Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? . Clinics, [S. l.], v. 66, n. 7, p. 1171–1175, 2011. DOI: 10.1590/S1807-59322011000700008. Disponível em: https://www.revistas.usp.br/clinics/article/view/19356.. Acesso em: 14 jun. 2024.